Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
19
EDSA Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
-2.35%
Day range:
$1.55 - $1.75
52-week range:
$1.55 - $5.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.05x
P/B ratio:
2.89x
Volume:
22.9K
Avg. volume:
26.4K
1-year change:
-66.12%
Market cap:
$5.7M
Revenue:
--
EPS (TTM):
-$1.93
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $328.8K | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -19.97% | -- | -- | -- | -- | |
| Cost of Revenues | $17.6K | -- | -- | -- | -- | |
| Gross Profit | $311.2K | -- | -- | -- | -- | |
| Gross Profit Margin | 94.65% | -- | -- | -- | -- | |
| R&D Expenses | $3.3M | $17.9M | $13.3M | $4.8M | $2.9M | |
| Selling, General & Admin | $3.4M | $5.7M | $5M | $4.4M | $4.1M | |
| Other Inc / (Exp) | -$370 | -$13K | -$21.1K | -$21.7K | -$6.3K | |
| Operating Expenses | $6.7M | $13.3M | $17.6M | $8.6M | $6.3M | |
| Operating Income | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800 | $800 | $800 | $800 | $800 | |
| Net Income to Company | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Basic EPS (Cont. Ops) | -$5.18 | -$7.70 | -$8.37 | -$0.42 | -$1.93 | |
| Diluted EPS (Cont. Ops) | -$5.18 | -$7.70 | -$8.37 | -$0.42 | -$1.93 | |
| Weighted Average Basic Share | $1.2M | $1.7M | $2.1M | $20M | $3.2M | |
| Weighted Average Diluted Share | $1.2M | $1.7M | $2.1M | $20M | $3.2M | |
| EBITDA | -$6.3M | -$13.2M | -$17.5M | -$8.5M | -$6.1M | |
| EBIT | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Revenue (Reported) | $328.8K | -- | -- | -- | -- | |
| Operating Income (Reported) | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Operating Income (Adjusted) | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $500 | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -99.88% | -- | -- | -- | -- | |
| Cost of Revenues | $2.3K | -- | -- | -- | -- | |
| Gross Profit | -$1.8K | -- | -- | -- | -- | |
| Gross Profit Margin | -362.8% | -- | -- | -- | -- | |
| R&D Expenses | $1.2M | $4.1M | $1.8M | $953.4K | $103.9K | |
| Selling, General & Admin | $853.9K | $1.4M | $1M | $1.4M | $900.5K | |
| Other Inc / (Exp) | -$5K | -$72K | -$13.7K | -$3.7K | -$11.4K | |
| Operating Expenses | $2M | $3.6M | $2.8M | $1.8M | $967.2K | |
| Operating Income | -$2M | -$3.6M | -$2.8M | -$1.8M | -$967.2K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$2M | -$3.7M | -$2.8M | -$1.7M | -$962.1K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$2M | -$3.7M | -$2.8M | -$1.7M | -$962.1K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2M | -$3.7M | -$2.8M | -$1.7M | -$962.1K | |
| Basic EPS (Cont. Ops) | -$1.54 | -$1.89 | -$1.09 | -$0.56 | -$0.29 | |
| Diluted EPS (Cont. Ops) | -$1.54 | -$1.89 | -$1.09 | -$0.56 | -$0.29 | |
| Weighted Average Basic Share | $1.3M | $1.9M | $2.3M | $3.1M | $3.2M | |
| Weighted Average Diluted Share | $1.3M | $1.9M | $2.3M | $3.1M | $3.2M | |
| EBITDA | -$2M | -$3.6M | -$2.8M | -$1.7M | -$923K | |
| EBIT | -$2M | -$3.6M | -$2.8M | -$1.8M | -$967.2K | |
| Revenue (Reported) | $500 | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2M | -$3.6M | -$2.8M | -$1.8M | -$967.2K | |
| Operating Income (Adjusted) | -$2M | -$3.6M | -$2.8M | -$1.8M | -$967.2K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $328.8K | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $17.6K | -- | -- | -- | -- | |
| Gross Profit | $311.2K | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.3M | $17.9M | $13.3M | $4.8M | $2.9M | |
| Selling, General & Admin | $3.4M | $5.7M | $5M | $4.4M | $4.1M | |
| Other Inc / (Exp) | -$400 | -$13K | -$21.1K | -$21.7K | -$6.3K | |
| Operating Expenses | $6.7M | $13.3M | $17.6M | $8.6M | $6.3M | |
| Operating Income | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800 | -- | -- | -- | -- | |
| Net Income to Company | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Basic EPS (Cont. Ops) | -$5.18 | -$7.56 | -$8.30 | -$2.95 | -$1.93 | |
| Diluted EPS (Cont. Ops) | -$5.18 | -$7.56 | -$8.30 | -$2.95 | -$1.93 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$6.3M | -$13.2M | -$17.5M | -$8.5M | -$6.1M | |
| EBIT | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Revenue (Reported) | $328.8K | -- | -- | -- | -- | |
| Operating Income (Reported) | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Operating Income (Adjusted) | -$6.4M | -$13.3M | -$17.6M | -$8.6M | -$6.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $17.9M | $13.3M | $4.8M | $2.9M | -- | |
| Selling, General & Admin | $5.7M | $5M | $4.4M | $4.1M | -- | |
| Other Inc / (Exp) | -$13K | -$21.1K | -$21.7K | -$6.3K | -- | |
| Operating Expenses | $13.3M | $17.6M | $8.6M | $6.3M | -- | |
| Operating Income | -$13.3M | -$17.6M | -$8.6M | -$6.3M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800 | $800 | $800 | $800 | -- | |
| Net Income to Company | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -- | |
| Basic EPS (Cont. Ops) | -$7.56 | -$8.30 | -$2.95 | -$1.93 | -- | |
| Diluted EPS (Cont. Ops) | -$7.56 | -$8.30 | -$2.95 | -$1.93 | -- | |
| Weighted Average Basic Share | $6.9M | $8.4M | $11.5M | $12.8M | -- | |
| Weighted Average Diluted Share | $6.9M | $8.4M | $11.5M | $12.8M | -- | |
| EBITDA | -$13.2M | -$17.5M | -$8.5M | -$6.1M | -- | |
| EBIT | -$13.3M | -$17.6M | -$8.6M | -$6.3M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$13.3M | -$17.6M | -$8.6M | -$6.3M | -- | |
| Operating Income (Adjusted) | -$13.3M | -$17.6M | -$8.6M | -$6.3M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $87.5K | $3.3M | $1.3M | $626.5K | $270.9K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $802.9K | $948.7K | $745.5K | $448.9K | $367.4K | |
| Total Current Assets | $8.1M | $12.1M | $9.1M | $6.4M | $1.7M | |
| Property Plant And Equipment | $174.8K | $111.6K | $31.2K | $100.1K | $18.4K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $2.5M | $2.4M | $2.3M | $2.2M | $2.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $10.8M | $14.6M | $11.6M | $8.9M | $3.8M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $69.7K | $78.8K | $19K | $74.7K | $19.9K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5M | $1.5M | $2.1M | $1.8M | $1.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.1M | $1.5M | $2.2M | $1.8M | $1.8M | |
| Common Stock | $18.5M | $34.9M | $42.5M | $46.6M | $47.2M | |
| Other Common Equity Adj | -$287.2K | -$205.3K | -$213.6K | -$214.7K | -$242.6K | |
| Common Equity | $6.6M | $13.1M | $9.4M | $7M | $2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.6M | $13.1M | $9.4M | $7M | $2M | |
| Total Liabilities and Equity | $10.8M | $14.6M | $11.6M | $8.9M | $3.8M | |
| Cash and Short Terms | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $87.5K | $3.3M | $1.3M | $626.5K | $270.9K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $802.9K | $948.7K | $745.5K | $448.9K | $367.4K | |
| Total Current Assets | $8.1M | $12.1M | $9.1M | $6.4M | $1.7M | |
| Property Plant And Equipment | $174.8K | $111.6K | $31.2K | $100.1K | $18.4K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $2.5M | $2.4M | $2.3M | $2.2M | $2.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $10.8M | $14.6M | $11.6M | $8.9M | $3.8M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $69.7K | $78.8K | $19K | $74.7K | $19.9K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5M | $1.5M | $2.1M | $1.8M | $1.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.1M | $1.5M | $2.2M | $1.8M | $1.8M | |
| Common Stock | $18.5M | $34.9M | $42.5M | $46.6M | $47.2M | |
| Other Common Equity Adj | -$287.2K | -$205.3K | -$213.6K | -$214.7K | -$242.6K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.6M | $13.1M | $9.4M | $7M | $2M | |
| Total Liabilities and Equity | $10.8M | $14.6M | $11.6M | $8.9M | $3.8M | |
| Cash and Short Terms | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Depreciation & Amoritzation | $57.6K | $118.8K | $118.2K | $183.5K | $186.1K | |
| Stock-Based Compensation | $598.4K | $3.2M | $2.3M | $1.2M | $537.5K | |
| Change in Accounts Receivable | $127.1K | -$3.2M | $2M | $562.8K | $356.3K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | |
| Capital Expenditures | $34.3K | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $19.1K | -$6.2K | -$5.7K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $29.8K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$29.5K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$532.9K | -$188.4K | -$328.1K | -$285.4K | -$107.8K | |
| Cash From Financing | $7.1M | $14.2M | $11.6M | $4.8M | $592K | |
| Beginning Cash (CF) | $5M | $7.2M | $7.8M | $7.1M | $5.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1M | $503.7K | -$655.3K | -$1.8M | -$4.3M | |
| Ending Cash (CF) | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Levered Free Cash Flow | -$5M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2M | -$3.7M | -$2.8M | -$1.7M | -$962.1K | |
| Depreciation & Amoritzation | $29K | $28.9K | $29K | $46K | $44.2K | |
| Stock-Based Compensation | $86.4K | $904.7K | $456K | $517.1K | $93.9K | |
| Change in Accounts Receivable | -$29.2K | $778.6K | $126.7K | -$586.4K | $284.8K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.7M | -$355.3K | -$5.6M | -$1.5M | -$967K | |
| Capital Expenditures | $4K | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3.5K | $1.5K | $40 | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $90 | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$7K | $161K | -$410 | -$71.3K | -$31.4K | |
| Cash From Financing | $3.2M | $221K | -$290 | $412.5K | -$31.4K | |
| Beginning Cash (CF) | $5.6M | $8.1M | $12.8M | $6.5M | $2M | |
| Foreign Exchange Rate Adjustment | $14K | -$80.5K | -$89.3K | -$40.2K | -$5.1K | |
| Additions / Reductions | $1.6M | -$132.8K | -$5.6M | -$1.1M | -$998.5K | |
| Ending Cash (CF) | $7.2M | $7.8M | $7.1M | $5.4M | $1M | |
| Levered Free Cash Flow | -$1.7M | -$353.9K | -$5.6M | -$1.5M | -$967K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6.4M | -$13.3M | -$17.5M | -$8.4M | -$6.2M | |
| Depreciation & Amoritzation | $57.6K | $118.8K | $118.2K | $183.5K | $186K | |
| Stock-Based Compensation | $598.4K | $3.2M | $2.3M | $1.2M | $537.5K | |
| Change in Accounts Receivable | $127.1K | -$3.2M | $2M | $562.8K | $356.3K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | |
| Capital Expenditures | $34.3K | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $19.1K | -$6.1K | -$5.7K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$188.4K | -$328.1K | -$285.4K | -$107.8K | |
| Cash From Financing | $7.1M | $14.2M | $11.6M | $4.8M | $592K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1M | $503.7K | -$655.3K | -$1.8M | -$4.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$5M | -$13.7M | -$12.3M | -$6.6M | -$4.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.3M | -$17.5M | -$8.4M | -$6.2M | -- | |
| Depreciation & Amoritzation | $118.8K | $118.2K | $183.5K | $186.1K | -- | |
| Stock-Based Compensation | $3.2M | $2.3M | $1.2M | $537.5K | -- | |
| Change in Accounts Receivable | -$3.2M | $2M | $562.8K | $356.3K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$13.7M | -$12.3M | -$6.6M | -$4.9M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.2K | -$5.7K | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$29.5K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$188.4K | -$328.1K | -$285.4K | -$107.8K | -- | |
| Cash From Financing | $14.2M | $11.6M | $4.8M | $592K | -- | |
| Beginning Cash (CF) | $32.5M | $42.4M | $29.3M | $14.5M | -- | |
| Foreign Exchange Rate Adjustment | $121.9K | -$93K | $76.9K | -$25.9K | -- | |
| Additions / Reductions | $503.7K | -$655.3K | -$1.8M | -$4.3M | -- | |
| Ending Cash (CF) | $33.2M | $41.7M | $27.6M | $10.1M | -- | |
| Levered Free Cash Flow | -$13.7M | -$12.3M | -$6.6M | -$4.9M | -- | |
Get EDSA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EDSA
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
2.89x
1.85x
Price / LTM sales
16.05x
1.86x
Growth Metrics
EDSA
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
--
-$0.20
Profitability
EDSA
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Dec
13
Next Earnings Date
Feb
7
Estimated Next Earnings Date
Mar
14
Balance Sheet
EDSA
Sector
Total cash
$1M
$47M
Short term investments
--
$45.2M
Total assets
$3.8M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
